1
0
0
(1 - 16 von 19
)
LinkedIn: Mirle Schemionek | LinkedIn
Mirle Schemioneks berufliches Profil anzeigen LinkedIn ist das weltweit größte professionelle Netzwerk, das Fach- und Führungskräften wie Mirle Schemionek ...
Mirle Schemionek Email & Phone NumberContactOut
contactout.com
What is Mirle Schemionek's role at University Hospital RWTH Aachen, Department of Hematology, Oncology, Hemostaseology and SCT? Mirle Schemionek is Head of the ... What is Mirle Schemionek's role at University Hospital RWTH Aachen, Department of Hematology, Oncology, Hemostaseology and SCT? Mirle Schemionek is Head of the ...
Eltrombopag Preserves the Clonogenic Potential of ...Directory of Open Access Journals
doaj.org
Mirle Schemionek-Reinders,; Susanne Isfort,; Jens Panse,; Tim H. Brümmendorf,; Fabian Beier. Affiliations. Margherita Vieri: 1 Department of Hematology, ... Mirle Schemionek-Reinders,; Susanne Isfort,; Jens Panse,; Tim H. Brümmendorf,; Fabian Beier. Affiliations. Margherita Vieri: 1 Department of Hematology, ...
PLOS ONE: Dissecting Genomic Aberrations in Myeloproliferative...
journals.plos.org
Contributed equally to this work with: Martin M. J. Kirschner, Mirle Schemionek. Affiliation Department of Hematology, Oncology, Hemostaseology, and Stem Cell ...
PLOS ONE: Identification of the Adapter Molecule MTSS1 as a Potential...
journals.plos.org
Mirle Schemionek. Contributed equally to this work with: Mirle Schemionek, Behzad Kharabi Masouleh. Affiliation Department of Hematology, ...
XBP1 promotes NRAS G12D pre-B acute lymphoblastic ...Wiley Online Library
onlinelibrary.wiley.com
von A Salimi · · Zitiert von: 1 — Mirle Schemionek-Reinders,. Mirle Schemionek-Reinders. Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation ... von A Salimi · · Zitiert von: 1 — Mirle Schemionek-Reinders,. Mirle Schemionek-Reinders. Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation ...
Targeting of BCR-ABL1 and IRE1α induces synthetic lethality ...Oxford Academic
academic.oup.com
von M Vieri · · Zitiert von: 9 — Mirle Schemionek ,. Mirle Schemionek. Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation. , Aachen,. Germany. Search for other ... von M Vieri · · Zitiert von: 9 — Mirle Schemionek ,. Mirle Schemionek. Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation. , Aachen,. Germany. Search for other ...
A phase I first-in-man study to investigate the ...Springer
link.springer.com
von J Metselaar · · Zitiert von: 2 — Amelie Boquoi, Roland Fenk, Mirle Schemionek, Susanne Isfort, Stefan Wilop & Martina Crysandt. Department of Hematology, Oncology and ... von J Metselaar · · Zitiert von: 2 — Amelie Boquoi, Roland Fenk, Mirle Schemionek, Susanne Isfort, Stefan Wilop & Martina Crysandt. Department of Hematology, Oncology and ...
Identification of the Adapter Molecule MTSS1 as a Potential ...PLOS
journals.plos.org
von M Schemionek · · Zitiert von: 29 — Mirle Schemionek. Contributed equally to this work with: Mirle Schemionek, Behzad Kharabi Masouleh. Affiliation: Department of Hematology, Oncology ... von M Schemionek · · Zitiert von: 29 — Mirle Schemionek. Contributed equally to this work with: Mirle Schemionek, Behzad Kharabi Masouleh. Affiliation: Department of Hematology, Oncology ...
Interplay between PI3K/mTOR Signaling and IRE1a-XBP1 ...The Conference Exchange
ash.confex.com
... Mirle Schemionek, PhD3*, Margherita Vieri, PhD4*, Tim H Brümmendorf, MD5, John B. Patterson6* and Behzad Kharabi Masouleh, MD7. 1Department of Hematology Mirle Schemionek, PhD3*, Margherita Vieri, PhD4*, Tim H Brümmendorf, MD5, John B. Patterson6* and Behzad Kharabi Masouleh, MD7. 1Department of Hematology ...
Targeting cytokine-induced leukemic stem cell persistence ...Haematologica
www.haematologica.org
von M Bütow · · Zitiert von: 4 — Mirle Schemionek. Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, Faculty of Medicine, RWTH Aachen ... von M Bütow · · Zitiert von: 4 — Mirle Schemionek. Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, Faculty of Medicine, RWTH Aachen ...
Tumor Suppressor Analysis in CMLNational Institutes of Health (NIH) (.gov)
pubmed.ncbi.nlm.nih.gov
von O Herrmann · — doi: _8. Authors. Oliver Herrmann , Mirle Schemionek. Affiliations. 1 Department of Hematology, Oncology, Hemostaseology, and Stem ... von O Herrmann · — doi: _8. Authors. Oliver Herrmann , Mirle Schemionek. Affiliations. 1 Department of Hematology, Oncology, Hemostaseology, and Stem ...
Myelofibrosis at diagnosis is associated with the failure ...National Institutes of Health (NIH) (.gov)
pubmed.ncbi.nlm.nih.gov
von H Jacobi · — ... Mirle Schemionek. Affiliations. 1 Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Faculty of Medicine ... von H Jacobi · — ... Mirle Schemionek. Affiliations. 1 Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Faculty of Medicine ...
Infliximab therapy together with tyrosine kinase inhibition ...X-MOL
www.x-mol.com
— ... Mirle Schemionek 1. Affiliation. Department of Hematology Oncology Hemostaseology and Stem Cell Transplantation Faculty of Medicine — ... Mirle Schemionek 1. Affiliation. Department of Hematology Oncology Hemostaseology and Stem Cell Transplantation Faculty of Medicine ...
Targeting cytokine-induced leukemic stem cell persistence ...X-MOL
www.x-mol.com
— ... Mirle Schemionek 1. Affiliation. Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, Faculty of Medicine, RWTH — ... Mirle Schemionek 1. Affiliation. Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, Faculty of Medicine, RWTH ...
Dissecting Genomic Aberrations in Myeloproliferative Neoplasms by...
journals.plos.org
Kirschner, Mirle Schemionek. Affiliation: Department of Hematology, ...
Alle Infos zum Namen "Mirle Schemionek"
sortiert nach Relevanz / Datum